Routine Surveillance of Healthcare-Associated Infections Misses a Significant Proportion of Invasive Aspergillosis in Patients with Severe COVID-19
- PMID: 35330275
- PMCID: PMC8954197
- DOI: 10.3390/jof8030273
Routine Surveillance of Healthcare-Associated Infections Misses a Significant Proportion of Invasive Aspergillosis in Patients with Severe COVID-19
Abstract
Rates of invasive aspergillosis (IA) among COVID-19 ICU patients seem to reach over 30% in certain settings. At Vienna General Hospital (VGH), all rooms in COVID-19 ICUs were put under negative pressure as a protective measure, thus increasing the risk of exposure to environmental pathogens for patients. Even though all ICU patients are surveilled for healthcare-associated infections (HAI), there were concerns that the routine protocol might not be sufficient for IA detection. We reviewed the electronic patient charts of all patients with COVID-19 admitted to ICUs between 1 March 2020 and 31 July 2021 for fungal co- or superinfections, comparing four diagnostic algorithms based on different recommendations for the diagnosis of IA (according to EORTC/MSG, BM-AspICU, IAPA and CAPA) to our routine surveillance protocol. We found that out of 252 patients who were admitted to the ICU during the study period, 25 (9.9%) fulfilled the criteria of probable or possible IA of at least one algorithm. The IAPA definitions detected 25 and the CAPA definition 23 probable and 2 possible cases, out of which only 16 were classified as hospital-acquired IA by routine surveillance. In conclusion, adjustment of the routine protocol using a classification system especially designed for respiratory viral illness seems useful for the surveillance of IA in a highly vulnerable patient cohort.
Keywords: COVID-19; intensive care; invasive aspergillosis; superinfection; surveillance.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU.Ann Intensive Care. 2021 Mar 8;11(1):41. doi: 10.1186/s13613-021-00827-3. Ann Intensive Care. 2021. PMID: 33683480 Free PMC article.
-
Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?J Fungi (Basel). 2021 May 15;7(5):388. doi: 10.3390/jof7050388. J Fungi (Basel). 2021. PMID: 34063556 Free PMC article.
-
A Comparison of Diagnostic Criteria for Invasive Pulmonary Aspergillosis in Critically Ill Patients.Infect Dis Ther. 2023 Jun;12(6):1641-1653. doi: 10.1007/s40121-023-00818-w. Epub 2023 May 18. Infect Dis Ther. 2023. PMID: 37199881 Free PMC article.
-
Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU-Practical Recommendations from an Expert Group for CAPA/IAPA Patients.J Fungi (Basel). 2023 Mar 2;9(3):312. doi: 10.3390/jof9030312. J Fungi (Basel). 2023. PMID: 36983480 Free PMC article.
-
Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements.Ann Intensive Care. 2021 Sep 15;11(1):136. doi: 10.1186/s13613-021-00923-4. Ann Intensive Care. 2021. PMID: 34524562 Free PMC article. Review.
Cited by
-
COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.J Microbiol Immunol Infect. 2023 Jun;56(3):442-454. doi: 10.1016/j.jmii.2022.12.004. Epub 2022 Dec 15. J Microbiol Immunol Infect. 2023. PMID: 36586744 Free PMC article. Review.
-
Identification of Histopathological Biomarkers in Fatal Cases of Coronavirus Disease: A Study on Lung Tissue.Diagnostics (Basel). 2023 Jun 12;13(12):2039. doi: 10.3390/diagnostics13122039. Diagnostics (Basel). 2023. PMID: 37370934 Free PMC article.
-
Indoor environment assessment of special wards of educational hospitals for the detection of fungal contamination sources: A multi-center study (2019-2021).Curr Med Mycol. 2022 Dec;8(4):1-8. doi: 10.32598/CMM.2023.1370. Curr Med Mycol. 2022. PMID: 37736609 Free PMC article.
References
-
- Taccone F.S., Abeele A.-M.V.D., Bulpa P., Misset B., Meersseman W., Cardoso T., Paiva J.-A., Blasco-Navalpotro M., De Laere E., Dimopoulos G., et al. Epidemiology of invasive aspergillosis in critically ill patients: Clinical presentation, underlying conditions, and outcomes. Crit. Care. 2015;19:7. doi: 10.1186/s13054-014-0722-7. - DOI - PMC - PubMed
-
- Burghi G., Lemiale V., Seguin A., Lambert J., Lacroix C., Canet E., Moreau A.-S., Ribaud P., Schnell D., Mariotte E., et al. Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis. Intensive Care Med. 2011;37:1605–1612. doi: 10.1007/s00134-011-2344-8. - DOI - PubMed
-
- Schauwvlieghe A.F.A.D., Rijnders B.J.A., Philips N., Verwijs R., Vanderbeke L., Van Tienen C., Lagrou K., Verweij P.E., Van De Veerdonk F.L., Gommers D., et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study. Lancet Respir. Med. 2018;6:782–792. doi: 10.1016/S2213-2600(18)30274-1. - DOI - PubMed
-
- Bonnet S., Duléry R., Regany K., Bouketouche M., Magro L., Coiteux V., Alfandari S., Berthon C., Quesnel B., Yakoub-Agha I. Long-term follow up of invasive aspergillosis in allogeneic stem cell transplantation recipients and leukemia patients: Differences in risk factors and outcomes. Curr. Res. Transl. Med. 2017;65:77–81. doi: 10.1016/j.retram.2017.05.003. - DOI - PubMed
-
- Nicolle M.C., Bénet T., Thiebaut A., Bienvenu A.-L., Voirin N., Duclos A., Sobh M., Cannas G., Thomas X., Nicolini F.-E., et al. Invasive aspergillosis in patients with hematologic malignancies: Incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. Haematologica. 2011;96:1685–1691. doi: 10.3324/haematol.2011.044636. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources